Inspire Medical Systems, Inc.

NYSE:INSP

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🩺 Medical Instruments

Location

United States

Market Cap

USD 2.36 B

Share Price

USD 79.63

Avg Daily Volume

834,237

Change (1 day)

0.62%

Change (1 year)

-58.79%

Change (YTD)

-57.05%

Inspire Medical Systems, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2025: USD 81.21 M

Inspire Medical Systems, Inc. EBITDA is USD 81.21 M for the Trailing 12 Months (TTM) ending June 30, 2025, a -1,629.11% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Inspire Medical Systems, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2024 was USD -5.31 M, a -89.25% change year over year.
Inspire Medical Systems, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2023 was USD -49.42 M, a 25.39% change year over year.
Inspire Medical Systems, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2022 was USD -39.41 M, a -10.12% change year over year.
Inspire Medical Systems, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2021 was USD -43.85 M, a -18.56% change year over year.